SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Escalating U.S.-Iran tensions around the Strait of Hormuz, higher oil prices and renewed expectations for restrictive Fed policy are driving QQQ volatility. Traders are divided between expecting further pressure on tech from rising yields and inflation, and betting that resilient AI and semiconductor leadership will support a rebound.

Zoracles

A sharp rally accompanied by unusually heavy volume has drawn attention to ZORA, with traders speculating that its low market capitalization and sizable futures short interest could amplify a short squeeze. The community is divided between viewing the move as momentum around Zoras creator-token and attention-market ecosystem and warning that it may be another volatile pump-and-dump.

Helium is a decentralized machine network powered by a physical blockchain. The network is created by gateways who also double as miners on our network. These gateway operators can earn tokens based on coverage they provide as well as transaction fees gained from machines connecting to their gateway  Helium is a new cryptocurrency. Hotspots earn for providing and validating wireless coverage and when devices on the network connect to the internet through Hospots  Helium is mined and distributed to Hotspot Owners, Helium Inc, and investors. There is no pre-mine of Helium, and every month approximately 5,000,000 new Helium are minted.  At the end of each mining period, roughly every 30 to 60 mins, Helium is distributed according to the allocation shown:

Helium

Celina, Texas adoption of Heliums networkconverting existing city WiFi into carrier-grade coveragehas become the main catalyst, alongside attention on AT&T carrier offload and Heliums broader DePIN utility. Bullish traders view the deployment and rising usage as evidence of real-world adoption, while skeptics point to token dilution, weak hotspot economics, and possible pump-and-dump behavior.

Gap, Inc. operates as a global apparel retail company, which offers clothing, apparel, accessories, and personal care products for men, women, and children. The firm operates through the following segments: Gap Global, Old Navy Global, Banana Republic Global, Athleta, and Other. The Gap Global segment includes apparel and accessories for men and women under the Gap brand, along with the GapKids, BabyGap, GapMaternity, GapBody, and GapFit collections. The Old Navy Global segment offers clothing and accessories for adults and children. The Banana Republic Global segment provides clothing, eyewear, jewelry, shoes, handbags, and fragrances. The Athleta segment offers fitness apparel for women. The company founded by Donald G. Fisher and Doris F. Fisher in July 1969 and is headquartered in San Francisco, CA.

Gap, Inc.

Better-than-feared fiscal second-quarter results, raised full-year outlook, and the appointment of Michael Francis to lead Old Navy are driving attention, with strong Gap-brand sales supporting a broader turnaround narrative. Traders remain divided between bullish momentum and short-squeeze expectations versus concerns about Old Navys weakness, tariff-related benefits, and profit-taking after the sharp rally.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Renewed U.S.-Iran strikes near the Strait of Hormuz, and Irans retaliation, have driven discussion about higher oil prices, inflation, and potential Federal Reserve rate hikes weighing on the S&P 500. Traders are split between expecting further downside and viewing the weakness as a buy-the-dip opportunity, with some arguing markets will remain resilient despite the geopolitical escalation.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

A better-than-expected quarterly report, improved outlook, firm offshore day rates and growing backlog are driving renewed interest in Transocean, alongside speculation that high short interest could amplify the move. Traders remain divided over whether these fundamentals can overcome Valaris merger uncertainty, dilution, leverage and persistent volatility in oil and offshore drilling.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

A rebound in Bitcoin and broader crypto activity is driving traders to view Robinhood as a leveraged crypto-trading and blockchain play, with additional enthusiasm around Robinhood Chain, tokenized assets, and prediction markets. Bullish participants expect stronger transaction volumes and revenue, while skeptics point to the stocks volatility, resistance near recent highs, and concerns about selling pressure or manipulation.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

SpaceXs FCC scrutiny of Rocket Labs proposed Iridium acquisition is driving the main debate, with traders weighing increased regulatory and merger risk against the strategic value of the deal. The discussion is broadly bearish on near-term price action, amplified by concerns about insider selling, ATM dilution and Neutron delays, while long-term bulls view the acquisition and Neutron progress as intact growth drivers.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Strait of Hormuz disruptions, tanker attacks and the broader Iran conflict are driving attention to USO, with traders debating whether constrained oil flows and low strategic reserves signal a sustained supply shock. The Venezuela oil agreement and reports of alternative shipping routes are viewed by bearish traders as potential offsets, though many argue added Venezuelan production would take years to materially affect supply.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Iran-war uncertainty and potential Strait of Hormuz disruption have kept oil prices and fuel costs at the center of NCLH trading, with the community frustrated that the stock has not rallied even when crude declines. Analyst target cuts and concerns about debt, management, and the turnaround add pressure, while some traders view insider or activist buying and resilient cruise demand as reasons to remain bullish.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial

FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial PR Newswire HOUSTON, Aug. 27, 2026 HOUSTON, Aug. 27, 2026 /PRNewswire...

FibroBiologics Regains Compliance with Nasdaq Trading Rules

FibroBiologics Regains Compliance with Nasdaq Trading Rules FibroBiologics Regains Compliance with Nasdaq Trading Rules PR Newswire HOUSTON, Aug. 26, 2026 HOUSTON, Aug. 26, 2026 /PRNewswire/ -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics" or the "Company"), a clinical-stage biotechnology...

FibroBiologics Appoints Leigh Steinberg to Board of Directors

FibroBiologics Appoints Leigh Steinberg to Board of Directors FibroBiologics Appoints Leigh Steinberg to Board of Directors PR Newswire HOUSTON, Aug. 24, 2026 Legendary Sports Agent, Attorney, and Longtime Advocate for Human Longevity and Brain Health Joins BoardHOUSTON, Aug. 24, 2026 /PRNewswire...

FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease

FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease PR Newswire HOUSTON, Aug. 20, 2026...

FibroBiologics Says Preclinical Data Shapes Design of Further Studies for Degenerative Joint Treatment

FibroBiologics reports promising preclinical results for a novel joint repair therapy, offering a faster, scalable alternative to surgery.read more...

FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints

FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints PR Newswire HOUSTON, Aug. 18, 2026 Animal trials show...

FibroBiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insulin-Producing Islets

FibroBiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insulin-Producing Islets FibroBiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insulin-Producing Islets PR Newswire...

FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage

FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage PR Newswire HOUSTON, Aug. 5, 2026 Granted claims cover Sox9-based conversion of fibroblasts into...

FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate

FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate PR Newswire HOUSTON, July 31, 2026 - First...

FibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors

FibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors FibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors PR Newswire HOUSTON, July 9, 2026 Microbiologist, Retired NASA Astronaut, and Founding Director of the University of Pittsburgh Trivedi Institute...

FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.

FibroBiologics Inc

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a positive week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

FBLG FibroBiologics Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest FBLG News